News Overview

Date
Apr 24, 2025

White Paper | Cutting Edge Research & Development in the Field of Haemophilia A | Update 2025

Teaser text This Whitepaper represents an update of cutting edge Research & Development in the field of haemophilia A. The current drug pipeline includes promising new treatment approaches that will ... Read more
Date
Apr 15, 2025

White Paper | Obesity with and without Type 2 Diabetes Mellitus | Update April 2025

Teaser text This Whitepaper represents an update of cutting edge Research & Development in the field of obesity with or without type-2 diabetes mellitus. The current drug pipeline includes promising ... Read more
Date
Nov 04, 2024

Publication | Antimicrobial Resistance - The Silent Pandemic | Review Article focussing on the Antibiotic Crisis

Teaser text In 2019, the WHO declared Antimicrobial Resistance as one of ten threats to global health. In this review we describe the factors contributing to the antibiotic crisis and the efforts to develop ... Read more
Date
Jun 13, 2024

White Paper | Therapeutic Concepts for Obesity and Related Diseases inc. HFpEF - Part 3

Teaser text In Part 3, the diverse phenotypes of heart failure (HF) will be discussed with a special focus on the cardiometabolic HF phenotype with preserved ejection fraction (HFpEF). The pathophysiology ... Read more
Date
Apr 26, 2024

White Paper | Therapeutic Concepts for Obesity and Related Diseases inc. NAFLD/NASH - Part 2

Teaser text In Part 2 the current pharmacological approaches for the treatment of NAFLD/NASH with or without obesity will be presented and discussed based on current research and applicable guidelines ... Read more
Date
Mar 26, 2024

White Paper | Therapeutic Concepts for Obesity and Related Diseases inc. Type-2 Diabetes Mellitus - Part 1

Teaser text The CRO has written a Whitepaper based on our experience in the conduct of early phase projects for new anti-obesity drugs. We want to share our expertise in this special Whitepaper ... Read more
Date
Dec 20, 2023

White Paper | Asthma Update 2023 Part 2: Asthma Drug Pipeline 2023 & Discussion of New Drug Candidates

Teaser text The CRO has written a Whitepaper based on our long-standing experience in the conduct of early phase projects for new asthma medicines. We want to share our expertise in this special ... Read more
Date
Oct 06, 2023

White Paper | Asthma Update 2023 Part 1: Modern Asthma Management inc. Asthma Diagnostics & Therapy

Teaser text The CRO has written a Whitepaper based on our long-standing experience in the conduct of early phase projects for new asthma medicines. We want to share our expertise in this special ... Read more
Date
Jul 20, 2023

Review Article | Discussion of current insights to Long-COVID and associated research efforts

Teaser text The CRO has published a Review article discussing the current knowledge on Long-COVID and the efforts by the pharmaceutical industry, medical device companies as well as academic ... Read more
Date
May 09, 2023

Newsletter May 2023 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (May 2023). Read more
Date
Apr 05, 2023

Newsletter March 2023 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (March 2023). Read more
Date
Mar 03, 2023

White Paper | RNA-based Therapies: Significant Developments and Challenges

Teaser text CRO has released a white paper on RNA-based therapies to provide an overview of significant developments and challenges in this highly relevant field. Read more
Date
Dec 15, 2022

Newsletter December 2022 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (December 2022). Read more
Date
Dec 02, 2022

White Paper | EU CTR: What do you need to consider when planning clinical trials to avoid delays in their initiation?

Teaser text CRO has released a white paper on the EU-Clinical Trial Regulation 536/2014 to provide guidance on what to consider now when planning clinical trials to avoid delays in their initiation Read more
Date
Nov 18, 2022

Newsletter November 2022 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (November 2022). Read more
Date
Oct 17, 2022

Newsletter October 2022 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (October 2022). Read more
Date
Sep 26, 2022

Crédit d'Impôt Recherche (CIR) - Approval of CRO by the French Ministry of Higher Education and Research

Teaser text Recognition of Charité Research Organisation GmbH providing research activities within the framework of the French research tax credit scheme for the years 2021, 2022 & 2023. Read more
Date
May 04, 2022

Newsletter April/May 2022 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (April/May 2022). Read more
Date
Apr 22, 2022

International Clinical Trials Day 2022 - Charité Research Organisation will be there

Teaser text Clinical studies in a nutshell - an information day at the Langenbeck-Virchow-Haus in Berlin
Before a new drug or medical device can be used to treat patients, its efficacy and safety... Read more
Date
Nov 17, 2021

Newsletter November 2021 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (November 2021). Read more
Date
Jul 22, 2021

Press Release - Establishment of Support Association International Clinical Trials Day

Teaser text Seven companies, active in clinical research, came together to establish an association to support the "International Clinical Trials Day" with the joint mission to advance information on clinical research. Read more
Date
Jul 05, 2021

Newsletter July 2021 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (July 2021). Read more
Date
Jun 17, 2021

Newsletter June 2021 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (June 2021). Read more
Date
May 10, 2021

Newsletter May 2021 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (May 2021). Read more
Date
Apr 06, 2021

Newsletter March/April 2021 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (March/April 2021). Read more
Date
Feb 25, 2021

Newsletter February 2021 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (February 2021). Read more
Date
Aug 27, 2020

Newsletter September 2020 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (September 2020). Read more
Date
Jun 15, 2020

Newsletter July 2020 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (July 2020). Read more
Date
Mar 19, 2020

CoronaVirus (SARS-CoV-2) Situation Update: Charité Research Organisation Operational Status

Teaser text CoronaVirus (SARS-CoV-2) situation update: Charité Research Organisation operational status, impact on ongoing study activities, SARS-CoV-2 clinical trial opportunities (19th March 2020) Read more
Date
Feb 27, 2020

Newsletter February 2020 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (February 2020). Read more
Date
Feb 06, 2020

36th annual congress hosted by the German Society for Pharmaceutical Medicine (March 12/13, 2020)

Teaser text Charité Research Organisation will attend the 36th annual congress hosted by the German Society for Pharmaceutical Medicine (DGPharMed) on 12/13 March in Berlin. Read more
Date
Jan 31, 2020

Newsletter January 2020 of the Haematologic-Oncologic Phase I Unit of Charité/Charité Research Organisation

Teaser text The Haematologic-Oncologic Phase I Unit of Charité - Universitätsmedizin Berlin and Charité Research Organisation provides an update on studies with active enrolment (January 2020). Read more
Date
Aug 19, 2019

Charité Research Organisation as German ambassador for medical biotechnology

Teaser text The Charité Research Organisation was honored this year from the GTAI to represent the German market and its companies in the field of medical biotechnology. Read more
Date
May 29, 2019

Unraveling the secrets of the human brain in health and disease - initiation of a clinical study in depression

Teaser text Little is known about how our brains enable us to store memory, to be conscious, to perceive time, and to make decisions – the human brain hides mysteries science still cannot explain. Read more
Date
Apr 18, 2019

International Day of Clinical Trials in the Urania Berlin – the Charité Research Organisation (CRO) is represented

Teaser text I should be the first... !? At some point, a newly developed medicine must be given to a human for the first time. What happens during these first-time-in-human studies... Read more
Date
Mar 15, 2019

Systemic Lupus Erythematosus trial with Charité Research Organisation – head start and rapid enrollment

Teaser text The Charité Research Organisation has – once again – surpassed all expectations by enrolling 4 patients and scheduling another 4 patients within the first two weeks of the study. Read more
Date
Mar 14, 2019

Recruitment at a tearing pace in EMA compliant dose level study in subjects with reduced renal function

Teaser text In an on-going study to test safety and pharmacokinetics of a new treatment, the Charité Research Organisation has successfully included the 24th patient within the first 3 months of the study. Read more
Date
Dec 10, 2018

First patient enrolled in a trial for moderate to severe psoriasis at the Charité Research Organisation

Teaser text We are happy to announce that we have just enrolled the first psoriatic patient in an open-label phase 2a trial, assessing the clinical efficacy and safety of a new, potential treatment. Read more
Date
Oct 30, 2018

Charité – in 2018 again recognised as Germany's best clinic

Teaser text The German journal Focus analysed, reviewed and ranked — for the 7th time in a row — the Charité as the best hospital in Germany. Scores were based on several factors, including the medical and caretaking performance. Read more
Date
Oct 11, 2018

BioJapan 2018 World Business Forum - CRO's in!

Teaser text BioJapan 2018 World Business Forum - BioJapan has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities for almost two decades. Read more
Date
Aug 14, 2018

Completion of recruitment for a Phase I MS trial

Teaser text Recently we finished recruiting for a Phase I trial in patients with progressive multiple sclerosis. This randomized, double-blind, placebo-controlled study was designed to assess the safety and tolerability of a new biologic as well as the pharmacodynamics...
Read more
Date
Jun 23, 2018

MAD/Phase IIa T2D study publication available

Teaser text As of today you can access a new paper published in The Lancet on 22 June 2018 on a combined multiple-ascending dose (MAD) and Phase IIa study in n=112 patients with controlled type 2 diabetes (HbA1c levels between 6.5–8.5%) via... Read more
Date
Jan 31, 2018

Relocation of Charité Research Organisation's Phase I Unit

Teaser text In January 2018 CRO’s Phase I unit moved from Campus Virchow-Klinikum (CVK) to Campus Mitte at Charité – Universitätsmedizin Berlin. Located at the very heart of Charité’s historic campus, the new facilities underwent extensive modernisation ... Read more
Date
Nov 28, 2017

Phase IIa Sjögren Syndrome Case Study available

Teaser text As of today you can access our first case study that illustrates how - with our help - you can reach Proof of Concept faster. This particular case study deals with a  Phase IIa, single dose, double-blind, placebo-controlled, parallel study to assess the PD, PK ... Read more
Date
Nov 09, 2017

Bacteriophages join the fight against infection

Teaser text (Hannover, Germany) Bacteria worldwide keep developing new resistances to antibiotics. Alternative therapies are urgently needed to meet this challenge. To this end, the Fraunhofer Institute for Toxicology and Experimental ... Read more
Date
Nov 06, 2017

Meet Charité Research at BioEurope 2017

Teaser text Charité Research Organisation will be present at the 2017 BioEurope in Berlin from November 6 to November 8. If you would like to meet, please contact us via enquiries@charite-research.org, +49-30-450 539 211 or the ... Read more